NCT02687451View on ClinicalTrials.gov

Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

PHASE3TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 1, 2020

Study Completion Date

September 15, 2020

Conditions
Post-Operative PainAcute Pain
Interventions
DRUG

Oxymorphone HCl

Oral liquid and injection; dose to be determined by Independent Data Monitoring Committee (IDMC).

DRUG

Placebo

Placebo Comparator for the double-blinded, placebo-controlled multiple-dose phase.

Trial Locations (3)

27710

Endo Clinical Trial Site #2, Durham

75235

Endo Clinical Trial Site #1, Dallas

77030

Endo Clinical Trial Site #4, Houston

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY